Sonic Healthcare Germany has signed binding agreements to acquire the Diagnosticum Group of laboratories. The Diagnosticum Group provides services in the fields of laboratory medicine, microbiology, pathology and human genetics at nine locations in south-eastern Germany.
The transaction is subject to customary closing conditions, including regulatory clearances. Raue advises Sonic Healthcare on the regulatory aspects of the transaction.
Raue has been advising Sonic Healthcare extensively on regulatory issues and assisting with acquisitions in Germany for many years.
About Sonic Healthcare
Sonic Healthcare is one of the world’s leading providers of medical diagnostic services. The group offers highly specialized laboratory diagnostics to general practitioners and specialists as well as hospitals and non-profit and public health facilities. With around 37,000 employees, Sonic Healthcare is represented worldwide in countries such as Australia, New Zealand, England, Ireland, Switzerland, Belgium, USA and Germany.